false
Catalog
Iterative Psychopharmacology: How to Apply Princip ...
View Presentation
View Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The transcript you provided is from a discussion led by Joe Goldberg, a clinical professor of psychiatry, focusing on the strategies for iterative psychopharmacology—a systematic, personalized approach to treatment that considers the unique symptoms and backgrounds of patients. Goldberg emphasizes the importance of not treating by diagnosis alone but rather adopting an N-of-one approach, evaluating each patient's individual characteristics and previous treatment outcomes to devise an intelligent, tailored treatment plan.<br /><br />He highlights the need for a roadmap in treatments, acknowledging that successive pharmacological steps often require reevaluation due to the complex nature of psychopharmacological impacts on patients. The approach involves using patient-specific decision-analytic matrices, decision trees, pros and cons assessments, and contingency planning. These tools help in balancing patient and provider treatment priorities while accounting for both probabilistic and deterministic forms of thinking about treatment outcomes.<br /><br />Goldberg also stresses the use of shared decision-making in clinical practice and discusses the importance of framing hypotheses to tailor treatments effectively. He introduces the concept of evaluating treatment resistance, the potential role of machine learning, and baseline patient characteristics or moderators (like age and comorbidities) that might predict outcomes.<br /><br />Alongside him, Steven Stahl, another expert in psychopharmacology, builds on this by discussing the importance of thinking strategically, akin to playing chess, to anticipate future treatment needs using pharmacokinetic insights and therapeutic drug monitoring. The goal is to ensure effective treatment while managing side effects and setting a longitudinal plan for patients.<br /><br />The session concludes with Michael Thase, offering insights on maintaining morale in treating difficult cases by ensuring patient engagement in their treatment plan and emphasizing the therapeutic relationship's benefit.
Keywords
psychopharmacology
iterative treatment
personalized approach
N-of-one approach
decision-analytic matrices
shared decision-making
treatment resistance
machine learning
patient characteristics
pharmacokinetics
therapeutic drug monitoring
treatment outcomes
therapeutic relationship
×
Please select your language
1
English